Anatomic Stage IIIA Breast Cancer AJCC v8 Withdrawn Phase 0 Trials for Atezolizumab (DB11595)

IndicationStatusPhase
DBCOND0109626 (Anatomic Stage IIIA Breast Cancer AJCC v8)Withdrawn0
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04249167Cryoablation, Atezolizumab/Nab-paclitaxel for Locally Advanced or Metastatic Triple Negative Breast CancerTreatment